{"component": "contracts", "props": {"contracts": [{"intro": "This Amended and Restated License Agreement (\u201cAgreement\u201d) is made and entered into on the __ day of March, 2012, effective as of the 25th day of May, 2010 (\u201cEffective Date\u201d), by and between: Tel Hashomer - Medical Research, Infrastructure and Services LTD, a private company duly incorporated under the laws of the State of Israel having its registered office at Tel Hashomer, Israel, 52621, (\u201cTHM\u201d),and Ramot at Tel Aviv University Ltd. a wholly owned subsidiary of Tel-Aviv University duly incorporated under the laws of the State of Israel having its registered office at Tel-Aviv University, Ramat Aviv, Tel Aviv 61392, Israel (\u201cRamot\u201d). THM and Ramot shall be referred to in this Agreement together as \u201cLicensors\u201d;", "id": "7FxnOayoCKO", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-23_kitov.htm", "category_name": "License Agreement", "company_name": "Kitov Pharma Ltd.", "created": "March 31st, 2020", "published": true, "pretty": null, "uri": "/contracts/7FxnOayoCKO", "title": "THE SYMBOL \u201c[****]\u201d DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED AMENDED AND RESTATED...", "group_id": "7FxnOayoCKO", "group_samples": [{"label": "License Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/7FxnOayoCKO", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "7PmICcg7QZU", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420414050928/filename4.htm", "category_name": "Master Research Services Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 18th, 2014", "published": true, "pretty": null, "uri": "/contracts/7PmICcg7QZU", "title": "Dated 04 February 2014 Kitov Pharmaceutical Limited AND Java Clinical Research Limited Master Research Services Agreement", "group_id": "7PmICcg7QZU", "group_samples": [{"label": "Master Research Services Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/7PmICcg7QZU", "published": true}], "group_size": 1, "tags": [{"name": "Master Research Services Agreement", "type": "category", "uri": "/contracts/tagged/master-research-services-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Amendment Number 1 (the \u201cAmendment\u201d) to that certain Stock Purchase Agreement (the \u201cAgreement\u201d) previously entered into as of March 14, 2019, by and among Kitov Pharma Ltd., an Israeli publicly traded corporation (\u201cBuyer\u201d), certain stockholders of FameWave Ltd., an Israeli private corporation (the \u201cCompany\u201d), who are identified on Exhibit A attached thereto (collectively \u201cSellers\u201d and individually a \u201cSeller\u201d), and M. Arkin (1999) Ltd. of 6 Ha\u2019Choshlim St. Herzelia, Israel (the \u201cStockholder Representative\u201d), is hereby made and entered into as of April 7, 2019. Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "8MXgo6YkxD0", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390019005917/f6k040819ex99-1_kitovpharma.htm", "category_name": "Stock Purchase Agreement", "company_name": "Kitov Pharma Ltd.", "created": "April 8th, 2019", "published": true, "pretty": null, "uri": "/contracts/8MXgo6YkxD0", "title": "AMENDMENT TO STOCK PURCHASE AGREEMENT", "group_id": "8MXgo6YkxD0", "group_samples": [{"label": "Stock Purchase Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/8MXgo6YkxD0", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Development Services Agreement (the \"Agreement\"), is made and entered into, as of ________________, 2014, by and between Kitov Pharmaceuticals Holdings Ltd., an Israeli company with offices at Lev Hagiva, 11 Bet Hadfus Street, Jerusalem 95483, Israel (hereinafter \u201cKitov\u201d); and Dexcel Ltd., a company incorporated under the laws of Israel, with offices at 1 Dexcel Street Or Akiva, 3060000, Israel (\"Dexcel\").", "id": "9bIeQYcuklb", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420414050928/filename3.htm", "category_name": "Development Services Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 18th, 2014", "published": true, "pretty": null, "uri": "/contracts/9bIeQYcuklb", "title": "development Services agreEment", "group_id": "9bIeQYcuklb", "group_samples": [{"label": "Development Services Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/9bIeQYcuklb", "published": true}], "group_size": 1, "tags": [{"name": "Development Services Agreement", "type": "category", "uri": "/contracts/tagged/development-services-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "The agreements attached to this email are agreed upon by the Parties thereto as the final drafts thereof. Annex A to the document entitled \u201cBinding Term Sheet\u201d is amended as follows:", "id": "9vOROm5S8yC", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016ex4xviii_kitovpharma.htm", "category_name": "Binding Term Sheet Amendment", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "May 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/9vOROm5S8yC", "title": "AMENDMENT TO BINDING Term Sheet Dated February 9, 2017 [unofficial translation from hebrew to english]", "group_id": "9vOROm5S8yC", "group_samples": [{"label": "Binding Term Sheet Amendment (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/9vOROm5S8yC", "published": true}], "group_size": 1, "tags": [{"name": "Binding Term Sheet Amendment", "type": "category", "uri": "/contracts/tagged/binding-term-sheet-amendment"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Stock Purchase Agreement (this \u201cAgreement\u201d) is entered into as of October 3, 2017, by and among Kitov Pharmaceuticals Holdings Ltd., an Israeli publicly traded corporation (\u201cBuyer\u201d), certain stockholders of TyrNovo Ltd., an Israeli private corporation (the \u201cCompany\u201d), who are identified on Exhibit A attached hereto (collectively \u201cSellers\u201d and individually a \u201cSeller\u201d), and Mr. Raanan Bar-Zohar, Adv. of Balter, Guth, Aloni & Co. Law Offices (the \u201cStockholder Representative\u201d). Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "a55FKylI3T", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390018002558/f20f2017ex2-13_kitovpharma.htm", "category_name": "Stock Purchase Agreement", "company_name": "Kitov Pharma Ltd.", "created": "March 5th, 2018", "published": true, "pretty": null, "uri": "/contracts/a55FKylI3T", "title": "STOCK PURCHASE AGREEMENT by and among KITOV PHARMACEUTICALS HOLDINGS LTD. as the Buyer and CERTAIN STOCKHOLDERS OF TYRNOVO LTD. as the Sellers and MR. RAANAN BAR-ZOHAR as the Stockholders Representative Dated as of October 3, 2017 STOCK PURCHASE AGREEMENT", "group_id": "a55FKylI3T", "group_samples": [{"label": "Stock Purchase Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/a55FKylI3T", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Amendment Number 2 (the \u201cAmendment\u201d) to that certain Stock Purchase Agreement (the \u201cAgreement\u201d) previously entered into as of March 14, 2019, by and among Kitov Pharma Ltd., an Israeli publicly traded corporation (\u201cBuyer\u201d), certain stockholders of FameWave Ltd., an Israeli private corporation (the \u201cCompany\u201d), who are identified on Exhibit A attached thereto (collectively \u201cSellers\u201d and individually a \u201cSeller\u201d), and M. Arkin (1999) Ltd. of 6 Ha\u2019Choshlim St. Herzelia, Israel (the \u201cStockholder Representative\u201d), as amended, is hereby made and entered into as of August 16, 2019. Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "a880OHMAbPR", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390019018142/ff12019ex10-19_kitov.htm", "category_name": "Stock Purchase Agreement", "company_name": "Kitov Pharma Ltd.", "created": "September 16th, 2019", "published": true, "pretty": null, "uri": "/contracts/a880OHMAbPR", "title": "AMENDMENT TO STOCK PURCHASE AGREEMENT", "group_id": "a880OHMAbPR", "group_samples": [{"label": "Stock Purchase Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/a880OHMAbPR", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "arHybTKztpv", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420415043326/filename3.htm", "category_name": "Master Research Services Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "July 20th, 2015", "published": true, "pretty": null, "uri": "/contracts/arHybTKztpv", "title": "Dated 04 February 2014 Kitov Pharmaceutical Limited AND Java Clinical Research Limited Master Research Services Agreement", "group_id": "arHybTKztpv", "group_samples": [{"label": "Master Research Services Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/arHybTKztpv", "published": true}], "group_size": 1, "tags": [{"name": "Master Research Services Agreement", "type": "category", "uri": "/contracts/tagged/master-research-services-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Share Purchase Agreement (this \u201cAgreement\u201d) is entered into as of February 1, 2023 (the \u201cEffective Date\u201d), by and among Purple Biotech Ltd, an Israeli publicly traded corporation (\u201cBuyer\u201d), and the shareholders of Immunorizon Ltd., an Israeli private corporation (the \u201cCompany\u201d), who are identified on Exhibit A attached hereto (collectively \u201cSellers\u201d and individually a \u201cSeller\u201d), and M. Arkin (1999) Ltd. of 6 Ha\u2019Choshlim St. Herzelia, Israel (the \u201cStockholder Representative\u201d). Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "aweKvmai9Of", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390023017024/f20f2022ex4-25_purple.htm", "category_name": "Share Purchase Agreement", "company_name": "Purple Biotech Ltd.", "created": "March 3rd, 2023", "published": true, "pretty": null, "uri": "/contracts/aweKvmai9Of", "title": "CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [*****] indicates the redacted confidential portions of this exhibit....", "group_id": "aweKvmai9Of", "group_samples": [{"label": "Share Purchase Agreement (Purple Biotech Ltd.)", "uri": "/contracts/aweKvmai9Of", "published": true}], "group_size": 1, "tags": [{"name": "Share Purchase Agreement", "type": "category", "uri": "/contracts/tagged/share-purchase-agreement"}, {"name": "Purple Biotech Ltd.", "type": "company", "uri": "/company/1614744/purple-biotech-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Stock Purchase Agreement (this \u201cAgreement\u201d) is entered into as of March 14, 2019 (the \u201cEffective Date\u201d), by and among Kitov Pharma Ltd., an Israeli publicly traded corporation (\u201cBuyer\u201d), the stockholders of FameWave Ltd., an Israeli private corporation (the \u201cCompany\u201d), who are identified on Exhibit A attached hereto (collectively \u201cSellers\u201d and individually a \u201cSeller\u201d), and M. Arkin (1999) Ltd of 6 Ha\u2019Choshlim St. Herzelia, Israel (the \u201cStockholder Representative\u201d). Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "b4vfsoPzJbH", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390019005687/f20f2018a1ex4-17_kitov.htm", "category_name": "Stock Purchase Agreement", "company_name": "Kitov Pharma Ltd.", "created": "April 3rd, 2019", "published": true, "pretty": null, "uri": "/contracts/b4vfsoPzJbH", "title": "THE SYMBOL \u201c[****]\u201d DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED STOCK PURCHASE AGREEMENT...", "group_id": "b4vfsoPzJbH", "group_samples": [{"label": "Stock Purchase Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/b4vfsoPzJbH", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT (this \u201cAmendment\u201d) is entered into effective as of the __ day of July 2015, by and between Tel Hashomer \u2013 Medical Research, Infrastructure and Services Ltd. (\u201cTHM\u201d), Ramot at Tel Aviv University Ltd. (\u201cRamot\u201d) and cCAM Biotherapeutics Ltd. (the \u201cCompany\u201d).", "id": "bfXIixl7BtB", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-25_kitov.htm", "category_name": "License Agreement", "company_name": "Kitov Pharma Ltd.", "created": "March 31st, 2020", "published": true, "pretty": null, "uri": "/contracts/bfXIixl7BtB", "title": "SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT", "group_id": "bfXIixl7BtB", "group_samples": [{"label": "License Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/bfXIixl7BtB", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the \u201cWarrant\u201d) certifies that, for value received, _____________ or its assigns (the \u201cHolder\u201d) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the \u201cInitial Exercise Date\u201d) and on or prior to 5:00 p.m. (New York City time) on ______1 (the \u201cTermination Date\u201d) but not thereafter, to subscribe for and purchase from Purple Biotech Ltd., a company organized under the laws of the State of Israel (the \u201cCompany\u201d), up to [\u25cf] Ordinary Shares, no par value per share of the Company (the \u201cWarrant Shares\u201d), represented by [\u25cf] American Depositary Shares (each, an \u201cADS\u201d and, collectively, the \u201cADSs\u201d and the ADSs issuable upon exercise of this Warrant, the \u201cWarrant ADSs\u201d), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b", "id": "dvsEalSb0t6", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390025082116/ea025492801ex4-15_purple.htm", "category_name": "Warrant to Purchase Ordinary Shares", "company_name": "Purple Biotech Ltd.", "created": "August 29th, 2025", "published": true, "pretty": null, "uri": "/contracts/dvsEalSb0t6", "title": "WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES PURPLE BIOTECH LTD.", "group_id": "dvsEalSb0t6", "group_samples": [{"label": "Warrant to Purchase Ordinary Shares (Purple Biotech Ltd.)", "uri": "/contracts/dvsEalSb0t6", "published": true}], "group_size": 1, "tags": [{"name": "Warrant to Purchase Ordinary Shares", "type": "category", "uri": "/contracts/tagged/warrant-to-purchase-ordinary-shares"}, {"name": "Purple Biotech Ltd.", "type": "company", "uri": "/company/1614744/purple-biotech-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Development Services Agreement (the \"Agreement\"), is made and entered into, as of ________________, 2014, by and between Kitov Pharmaceuticals Holdings Ltd., an Israeli company with offices at Lev Hagiva, 11 Bet Hadfus Street, Jerusalem 95483, Israel (hereinafter \u201cKitov\u201d); and Dexcel Ltd., a company incorporated under the laws of Israel, with offices at 1 Dexcel Street Or Akiva, 3060000, Israel (\"Dexcel\").", "id": "eW11WOWco1n", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420415051166/filename2.htm", "category_name": "Development Services Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 21st, 2015", "published": true, "pretty": null, "uri": "/contracts/eW11WOWco1n", "title": "development Services agreEment", "group_id": "eW11WOWco1n", "group_samples": [{"label": "Development Services Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/eW11WOWco1n", "published": true}], "group_size": 1, "tags": [{"name": "Development Services Agreement", "type": "category", "uri": "/contracts/tagged/development-services-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS SHARE TRANSFER AGREEMENT (this \"Agreement\") is made as of the 2nd day of April 2013 (the \u201cExecution Date\u201d), by and among Mainrom Line Logistics Ltd., a public company traded on the Tel Aviv Stock Exchange (\u201cMainrom\u201d), Kitov Pharmaceuticals Ltd., a private company incorporated under the laws of the State of Israel (the \"Kitov\"), and all the shareholders of Kitov, as detailed in Schedule A attached hereto (collectively referred to as the \u201cShareholders\u201d), the controlling shareholder of Mainrom, Sheer Roichman (\u201cRoichman\u201d) and Haiku Capital Ltd. (Israeli Co # 51-3783209) (\u201cHaiku\u201d).", "id": "fYifNwP7H3l", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420414050928/filename5.htm", "category_name": "Share Transfer Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 18th, 2014", "published": true, "pretty": null, "uri": "/contracts/fYifNwP7H3l", "title": "SHARE TRANSFER AGREEMENT", "group_id": "fYifNwP7H3l", "group_samples": [{"label": "Share Transfer Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/fYifNwP7H3l", "published": true}], "group_size": 1, "tags": [{"name": "Share Transfer Agreement", "type": "category", "uri": "/contracts/tagged/share-transfer-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Tel-Aviv", "type": "jurisdiction", "uri": "/contracts/tagged/tel-aviv-il"}]}, {"intro": "BRIEFLY DESCRIBE ORIGINAL ASSUMPTION AND NEW REQUEST: The Original MSA dated 04 February refers only to Java Professional and Pass through Fees. This change order reflects total agree PI Fees for both Republic of Ireland and Northern Ireland. ROI fees which will be paid in euro to Java Clinical Research ltd who will then pass it on to the PIs upon receipt of invoices. NI fees will be paid in sterling directly to the single Investigator site at Celerion. A detailed service agreement will be exchanged directly between Kitov Pharmaceuticals and Celerion.", "id": "fgpc3PSe7l7", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420415051166/filename3.htm", "category_name": "Master Services Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 21st, 2015", "published": true, "pretty": null, "uri": "/contracts/fgpc3PSe7l7", "title": "Master Services Agreement Dated Between Kitov Pharmaceuticals Limited (Kitov)", "group_id": "fgpc3PSe7l7", "group_samples": [{"label": "Master Services Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/fgpc3PSe7l7", "published": true}], "group_size": 1, "tags": [{"name": "Master Services Agreement", "type": "category", "uri": "/contracts/tagged/master-services-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "fpa1DFAcYBk", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420416110421/v443237_ex1-2.htm", "category_name": "Engagement Letter", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "June 29th, 2016", "published": true, "pretty": null, "uri": "/contracts/fpa1DFAcYBk", "title": "June 29, 2016 Kitov Pharmaceuticals Holdings Ltd.", "group_id": "fpa1DFAcYBk", "group_samples": [{"label": "Engagement Letter (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/fpa1DFAcYBk", "published": true}], "group_size": 1, "tags": [{"name": "Engagement Letter", "type": "category", "uri": "/contracts/tagged/engagement-letter"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This FIRST AMENDMENT TO PRODUCT MANUFACTURING AGREEMENT (\u201cAmendment\u201d) is made as of the date of signature of the last Party to execute this Amendment (\u201cAmendment Effective Date\u201d), by and between:", "id": "gmGj8bAcnQ4", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/f20f2020ex4-29_purplebiotech.htm", "category_name": "Product Manufacturing Agreement", "company_name": "Purple Biotech Ltd.", "created": "March 16th, 2021", "published": true, "pretty": null, "uri": "/contracts/gmGj8bAcnQ4", "title": "THE SYMBOL \u201c[****]\u201d DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED FIRST AMENDMENT TO...", "group_id": "gmGj8bAcnQ4", "group_samples": [{"label": "Product Manufacturing Agreement (Purple Biotech Ltd.)", "uri": "/contracts/gmGj8bAcnQ4", "published": true}], "group_size": 1, "tags": [{"name": "Product Manufacturing Agreement", "type": "category", "uri": "/contracts/tagged/product-manufacturing-agreement"}, {"name": "Purple Biotech Ltd.", "type": "company", "uri": "/company/1614744/purple-biotech-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "h6gNl3OnImA", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420416110200/v443124_ex4-4.htm", "category_name": "Warrant Agent Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "June 28th, 2016", "published": true, "pretty": null, "uri": "/contracts/h6gNl3OnImA", "title": "KITOV PHARMACEUTICALS HOLDINGS LTD.", "group_id": "h6gNl3OnImA", "group_samples": [{"label": "Warrant Agent Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/h6gNl3OnImA", "published": true}], "group_size": 1, "tags": [{"name": "Warrant Agent Agreement", "type": "category", "uri": "/contracts/tagged/warrant-agent-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "h9CCYp3QJiC", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390025082116/ea025492801ex1-2_purple.htm", "category_name": "Underwriting Agreement", "company_name": "Purple Biotech Ltd.", "created": "August 29th, 2025", "published": true, "pretty": null, "uri": "/contracts/h9CCYp3QJiC", "title": "STRICTLY CONFIDENTIAL Purple Biotech Ltd.", "group_id": "h9CCYp3QJiC", "group_samples": [{"label": "Underwriting Agreement (Purple Biotech Ltd.)", "uri": "/contracts/h9CCYp3QJiC", "published": true}], "group_size": 1, "tags": [{"name": "Underwriting Agreement", "type": "category", "uri": "/contracts/tagged/underwriting-agreement"}, {"name": "Purple Biotech Ltd.", "type": "company", "uri": "/company/1614744/purple-biotech-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS FLOW OF FUNDS AGREEMENT (this \u201cAgreement\u201d) is made and entered into as of April 9, 2017, by and among Goldman Hirsh Partners Ltd. (the \u201cSeller\u201d), and Kitov Pharmaceuticals Holdings Ltd. an Israeli publicly traded corporation or its Affiliated party (the \"Buyer\"), (each of the Seller, and the Buyer shall also be referred to as a \u201cParty\u201d, and collectively as the \u201cParties\u201d).", "id": "hjsko6ArF4t", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016ex2x_kitovpharma.htm", "category_name": "Flow of Funds Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "May 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/hjsko6ArF4t", "title": "Flow of Funds Agreement", "group_id": "hjsko6ArF4t", "group_samples": [{"label": "Flow of Funds Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/hjsko6ArF4t", "published": true}], "group_size": 1, "tags": [{"name": "Flow of Funds Agreement", "type": "category", "uri": "/contracts/tagged/flow-of-funds-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Shareholders Agreement (the \u201cAgreement\u201d) is entered into effective as of February 9, 2017, by and between Kitov Pharmaceuticals Holdings Ltd. an Israeli publicly traded corporation (\u201cParent\u201d), on behalf of itself and, if Parent is not the buyer of the shares previously held by GHP (as defined hereunder), also on behalf of an as yet undetermined Affiliated party of Parent which shall, upon execution thereof by it, be deemed a Party to this Agreement Ab Initio (\u201cKitov\u201d) and Taoz \u2013 Company for Management of Companies Ltd. (\u201cTaoz\u201d); each of Kitov and Taoz a \u201cParty\u201d and collectively the \u201cParties\u201d.", "id": "hv3FNgyQuHT", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016ex4xix_kitovpharma.htm", "category_name": "Shareholders Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "May 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/hv3FNgyQuHT", "title": "Shareholders Agreement", "group_id": "hv3FNgyQuHT", "group_samples": [{"label": "Shareholders Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/hv3FNgyQuHT", "published": true}], "group_size": 1, "tags": [{"name": "Shareholders Agreement", "type": "category", "uri": "/contracts/tagged/shareholders-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This letter shall serve as an amendment (the \u201cAmendment\u201d) to that certain Warrant Agent Agreement, dated November 25, 2015 (the \"Agreement\") between Kitov Pharmaceuticals Holdings Ltd., a company incorporated under the laws of the State of Israel (the \"Company\"), and The Bank of New York Mellon (the \"Warrant Agent\"). Words used but not defined in this letter that are defined in the Agreement have the meanings assigned to them in the Agreement.", "id": "iSADC1MMMV9", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420416110421/v443237_ex4-1.htm", "category_name": "Warrant Agent Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "June 29th, 2016", "published": true, "pretty": null, "uri": "/contracts/iSADC1MMMV9", "title": "KITOV PHARMACEUTICALS HOLDINGS LTD.", "group_id": "iSADC1MMMV9", "group_samples": [{"label": "Warrant Agent Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/iSADC1MMMV9", "published": true}], "group_size": 1, "tags": [{"name": "Warrant Agent Agreement", "type": "category", "uri": "/contracts/tagged/warrant-agent-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Loan Agreement (the \u201cAgreement\u201d) is made as of the 25th day of August, 2013 (the \"Effective Date\") by and among Mainrom Line Logistics Ltd., of Tel Aviv, P.O. Box 48341 (the \u201cCompany\u201d) and certain Lenders, as shall be specified in Exhibit A (the \"Lenders\") (each of the Company and the Lenders, a \u201cParty\u201d, and together, the \"Parties\").", "id": "iq6Y6zrVO1p", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420414050928/filename7.htm", "category_name": "Loan Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "August 18th, 2014", "published": true, "pretty": null, "uri": "/contracts/iq6Y6zrVO1p", "title": "LOAN AGREEMENT", "group_id": "iq6Y6zrVO1p", "group_samples": [{"label": "Loan Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/iq6Y6zrVO1p", "published": true}], "group_size": 1, "tags": [{"name": "Loan Agreement", "type": "category", "uri": "/contracts/tagged/loan-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "j1JQZEVEtnp", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420416109927/v442997_ex1-2.htm", "category_name": "Exclusive Agency Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "June 27th, 2016", "published": true, "pretty": null, "uri": "/contracts/j1JQZEVEtnp", "title": "STRICTLY CONFIDENTIAL Kitov Pharmaceuticals Holdings Ltd.", "group_id": "j1JQZEVEtnp", "group_samples": [{"label": "Exclusive Agency Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/j1JQZEVEtnp", "published": true}], "group_size": 1, "tags": [{"name": "Exclusive Agency Agreement", "type": "category", "uri": "/contracts/tagged/exclusive-agency-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel (\u201cYissum\u201d) of the one part; and", "id": "j4au0WAgH9V", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016ex4xiv_kitovpharma.htm", "category_name": "License Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "May 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/j4au0WAgH9V", "title": "LICENSE AGREEMENT", "group_id": "j4au0WAgH9V", "group_samples": [{"label": "License Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/j4au0WAgH9V", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "Reference is made to the engagement letter (the \u201cEngagement Letter\u201d), dated as of June 24, 2020, by and between Kitov Pharma Ltd. (the \u201cCompany\u201d) and H.C. Wainwright & Co., LLC (\u201cWainwright\u201d), pursuant to which Wainwright shall serve as the exclusive agent in any offering of securities of the Company during the \u201cTerm\u201d (as defined in the Engagement Letter). Defined terms used herein but not defined herein shall have the meanings given to such terms in the Engagement Letter.", "id": "jBPiYhUJf7X", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390020015790/ea123437aex1-3_kitov.htm", "category_name": "Engagement Letter", "company_name": "Kitov Pharma Ltd.", "created": "June 25th, 2020", "published": true, "pretty": null, "uri": "/contracts/jBPiYhUJf7X", "title": "STRICTLY CONFIDENTIAL Kitov Pharma Ltd. One Azrieli Center (Round Tower) Tel Aviv, Israel 6701101 Attn: Isaac Israel, Chief Executive Officer", "group_id": "jBPiYhUJf7X", "group_samples": [{"label": "Engagement Letter (Kitov Pharma Ltd.)", "uri": "/contracts/jBPiYhUJf7X", "published": true}], "group_size": 1, "tags": [{"name": "Engagement Letter", "type": "category", "uri": "/contracts/tagged/engagement-letter"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "jGHyk7TOpsk", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390016018987/posam1115a2ex10iv_kitov.htm", "category_name": "Work Order", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "November 28th, 2016", "published": true, "pretty": null, "uri": "/contracts/jGHyk7TOpsk", "title": "SCHEDULE 1 WORK ORDER 2", "group_id": "jGHyk7TOpsk", "group_samples": [{"label": "Work Order (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/jGHyk7TOpsk", "published": true}], "group_size": 1, "tags": [{"name": "Work Order", "type": "category", "uri": "/contracts/tagged/work-order"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS SHARE TRANSFER AGREEMENT (this \"Agreement\") is made as of the 2nd day of April 2013 (the \u201cExecution Date\u201d), by and among Mainrom Line Logistics Ltd., a public company traded on the Tel Aviv Stock Exchange (\u201cMainrom\u201d), Kitov Pharmaceuticals Ltd., a private company incorporated under the laws of the State of Israel (the \"Kitov\"), and all the shareholders of Kitov, as detailed in Schedule A attached hereto (collectively referred to as the \u201cShareholders\u201d), the controlling shareholder of Mainrom, Sheer Roichman (\u201cRoichman\u201d) and Haiku Capital Ltd. (Israeli Co # 51-3783209) (\u201cHaiku\u201d).", "id": "jk0IcyS3k4x", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000114420415043326/filename4.htm", "category_name": "Share Transfer Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "July 20th, 2015", "published": true, "pretty": null, "uri": "/contracts/jk0IcyS3k4x", "title": "SHARE TRANSFER AGREEMENT", "group_id": "jk0IcyS3k4x", "group_samples": [{"label": "Share Transfer Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/jk0IcyS3k4x", "published": true}], "group_size": 1, "tags": [{"name": "Share Transfer Agreement", "type": "category", "uri": "/contracts/tagged/share-transfer-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Tel-Aviv", "type": "jurisdiction", "uri": "/contracts/tagged/tel-aviv-il"}]}, {"intro": "Whereas, Assignor is a party to a certain Restated and Amended License Agreement dated April 16, 2012, as amended (the \u201cAgreement\u201d), by and among Licensor and Assignor; and", "id": "kq9e6MMvDse", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-26_kitov.htm", "category_name": "Assignment and Assumption Agreement", "company_name": "Kitov Pharma Ltd.", "created": "March 31st, 2020", "published": true, "pretty": null, "uri": "/contracts/kq9e6MMvDse", "title": "ASSIGNMENT AND ASSUMPTION AGREEMENT", "group_id": "kq9e6MMvDse", "group_samples": [{"label": "Assignment and Assumption Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/kq9e6MMvDse", "published": true}], "group_size": 1, "tags": [{"name": "Assignment and Assumption Agreement", "type": "category", "uri": "/contracts/tagged/assignment-and-assumption-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Stock Purchase Agreement (this \u201cAgreement\u201d) is entered into as of January 12, 2017, by and among Kitov Pharmaceuticals Holdings Ltd., an Israeli publicly traded corporation (\u201cParent\u201d), on behalf of itself and, if Parent is not the buyer hereunder, also on behalf of an as yet undetermined Affiliated party of Parent which shall join this Agreement subsequent to the Closing (\u201cBuyer\u201d), and Goldman Hirsh Partners Ltd. (the \u201cSeller\u201d) which is a stockholder of Tyrovo Ltd., an Israeli private corporation (the \u201cCompany\u201d). Parent, Buyer and Seller are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "ksgGigAJjBl", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016ex2viii_kitovpharma.htm", "category_name": "Stock Purchase Agreement", "company_name": "Kitov Pharmaceuticals Holdings Ltd.", "created": "May 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/ksgGigAJjBl", "title": "STOCK PURCHASE AGREEMENT", "group_id": "ksgGigAJjBl", "group_samples": [{"label": "Stock Purchase Agreement (Kitov Pharmaceuticals Holdings Ltd.)", "uri": "/contracts/ksgGigAJjBl", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Kitov Pharmaceuticals Holdings Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharmaceuticals-holdings-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This LOCK-UP AND REGISTRATION RIGHTS AGREEMENT (this \u201cAgreement\u201d) is made as of the last date set forth on the signature page hereof by and between Kitov Pharma Ltd., an Israeli corporation (the \u201cCompany\u201d), and the sellers listed in Schedule A hereto (each a \u201cSeller\u201d and together the \u201cSellers\u201d).", "id": "lDQqvjHGKzE", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex10-22_kitovpharma.htm", "category_name": "Lock-Up and Registration Rights Agreement", "company_name": "Kitov Pharma Ltd.", "created": "March 10th, 2020", "published": true, "pretty": null, "uri": "/contracts/lDQqvjHGKzE", "title": "KITOV PHARMA LTD. LOCK-UP AND REGISTRATION RIGHTS AGREEMENT DATED [__], 2019 LOCK-UP AND REGISTRATION RIGHTS AGREEMENT", "group_id": "lDQqvjHGKzE", "group_samples": [{"label": "Lock Up and Registration Rights Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/lDQqvjHGKzE", "published": true}], "group_size": 1, "tags": [{"name": "Lock-Up and Registration Rights Agreement", "type": "category", "uri": "/contracts/tagged/lock-up-and-registration-rights-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Amendment Number 2 (the \u201cAmendment\u201d) to that certain Agreement previously entered into as of December 27, 2018, by and between Kitov Pharma Ltd., a company existing under the laws of the State of Israel with a principal place of business at One Azrieli Center, Round Tower, Floor 19, Tel Aviv, Israel (\u201cKitov\u201d), and Coeptis Pharmaceuticals, Inc., a Pennsylvania corporation with a principal place of business at 105 Bradford Road, Suite 420, Wexford, PA 15090 (\u201cCoeptis\u201d), as amended, (\u201cthe Agreement\u201d). Kitov and Coeptis are sometimes referred to individually herein as a \u201cParty\u201d and collectively as the \u201cParties.\u201d", "id": "lJboCHE39y2", "source_url": "https://www.sec.gov/Archives/edgar/data/1614744/000121390019025127/ff32019ex10-20_kitovpharma.htm", "category_name": "Amendment to Agreement", "company_name": "Kitov Pharma Ltd.", "created": "December 2nd, 2019", "published": true, "pretty": null, "uri": "/contracts/lJboCHE39y2", "title": "THE SYMBOL \u201c[****]\u201d DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED AMENDMENT TO AGREEMENT", "group_id": "lJboCHE39y2", "group_samples": [{"label": "Amendment to Agreement (Kitov Pharma Ltd.)", "uri": "/contracts/lJboCHE39y2", "published": true}], "group_size": 1, "tags": [{"name": "Amendment to Agreement", "type": "category", "uri": "/contracts/tagged/amendment-to-agreement"}, {"name": "Kitov Pharma Ltd.", "type": "company", "uri": "/company/1614744/kitov-pharma-ltd"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}], "next_curs": "", "cursor": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLNm96U1FVMWJiVzcYACAB"}}